Epidermal Growth Factor Receptor human
SIGMA/E3641 - buffered aqueous glycerol solution, 5,000-30,000 units/mg protein (Lowry)
Synonym: EGFR
MDL Number: MFCD01634808
Product Type: Chemical
SDS-PAGE Epidermal Growth Factor Receptor Human (Cat. No. E3641) was assessed on SDS-PAGE.
Epidermal
Growth Factor Receptor (EGFR) Pathway Research areas:
Cancer biology, Cell proliferation, Metabolism. Disease areas:
Breast, lung, stomach, gastrointestinal cancers, chronic kidney diseases,
glioblastomas.
| biological source | human |
| color | colorless |
| form | buffered aqueous glycerol solution |
| mol wt | ~170 kDa |
| packaging | pkg of 500UN |
| potency | 5000.00-30000.00 units/mg |
| Quality Level | 300  |
| shipped in | dry ice |
| specific activity | 5,000-30,000 units/mg protein (Lowry) |
| storage condition | avoid repeated freeze/thaw cycles |
| storage temp. | −70°C |
| UniProt accession no. | P00533  |
| Biochem/physiol Actions: | 170 kDa glycoprotein having EGF-activated protein tyrosine kinase activity; high levels of EGFR are expressed in approximately one third of human epithelial tumors, and in the cancers of the bladder, breast or lung that have poor clinical prognosis. |
| Biochem/physiol Actions: | EGF exerts its actions by binding to the EGF receptor (EGFR), a 170 kDa glycoprotein having EGF-activated protein tyrosine kinase activity. Even in the absence of EGF-like ligands, EGFR can participate in cellular responses elicited by several other stimuli. High levels of EGFR are expressed in approximately one third of human epithelial tumors, and in the cancers of the bladder, breast or lung that have poor clinical prognosis, hence the interest in targeting EGFR. |
| Biochem/physiol Actions: | Epidermal growth factor receptor (EGFR) has an essential role in normal developmental processes, and is mutated in multiple cancers. It is involved in the pathogenesis of epidermoid tumors, and thus, has extreme importance as a cancer therapeutic target. Gefitinib (GEF) and erlotinib act as EGFR inhibitors, and induce apoptosis in non-small cell lung cancer (NSCLC) cells. A truncated isoform, called EGFRvIII is linked to multiple cases of head and neck squamous cell carcinoma (HNSCC). In ~40% of glioblastoma multiforme (GBM), this gene is amplified. |
| General description: | Affinity purified from human carcinoma A431 cells. Epidermal growth factor receptor (EGFR) belongs to a family of cell surface receptors called receptor tyrosine kinases (RTKs), and is also the most studied member of this family. It is made up of an ectodomain (ECD), which contains four subdomains called DI-DIV, a transmembrane region, and a cytoplasmic tyrosine kinase domain (TKD). Binding of the ligand induces conformational changes in the ECD, which leads to the dimerization of EGFR. This results in the activation of the TKD, and the subsequent signal transduction. This receptor has a molecular weight of ∼178kDa. |
| Other Notes: | One unit (U) of the enzyme is defined as the amount needed to incorporate 1 pmol of phosphate into the substrate (KVEKIGEGTYGVVYK: 6 - 20 residue of p34cdc2) in 1 minute. |
| Packaging: | 500 units in glass bottle |
| Physical form: | Solution in 50% glycerol, containing 50 mM HEPES, pH 7.6, 150 mM NaCl, 0.1% Triton and 1 mM dithiothreitol |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| activity | specific activity: 5,000-30,000 units/mg protein (Lowry) |
| Storage Temp. | −70°C |
| UNSPSC | 12352202 |